Post by Evonik Health Care

Oral drug delivery is moving beyond the small intestine 💊 Targeting the ileocolonic region is rapidly emerging as a key strategy for next‑generation therapeutics - from microbiome‑based treatments to biologics and nucleic acids. Why? Because where a drug is released can be just as critical as how much is delivered. You can read about ileocolonic delivery in this article by our colleague Lucas Cusin, recently published in The Microbiome Times. The article discusses key systems, polymers, and platforms enabling ileocolonic delivery, such as: • Proven pH‑dependent EUDRAGIT® polymers for reliable, site‑specific release 🎯 • Multi‑trigger systems combining pH and microbiome activation for improved consistency • Innovative platforms like DuoCoat® to enable faster, more precise release • Ready‑to‑fill capsules such as EUDRACAP® colon to support sensitive APIs like live biotherapeutics A wide range of tools is enabling more reliable delivery, improved bioavailability, and new possibilities for complex therapies. 👉 Read the full article here: https://lnkd.in/dU9Tg7Zy #OralDrugDelivery #Microbiome #DrugDelivery #PharmaInnovation #EUDRAGIT #TargetedDelivery #EvonikHealthCare #BeyondChemistry